Arterial enhancement pattern predicts survival in patients with resectable and unresectable intrahepatic cholangiocarcinoma-Reference-Cited by-同舟云学术

Arterial enhancement pattern predicts survival in patients with resectable and unresectable intrahepatic cholangiocarcinoma

Published:2022-03 Issue: Volume:40 Page:101696
ISSN:0960-7404
Container-title:Surgical Oncology
language:en
Short-container-title:Surgical Oncology

Author:

Panettieri Elena^ORCID,Maki Harufumi,Kim Bradford J.^ORCID,Kang HyunSeon Christine^ORCID,Cox Veronica,Vega Eduardo A.^ORCID,Mizuno Takashi,Pant Shubham,Javle Milind,Vauthey Jean-Nicolas,Kawaguchi Yoshikuni

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Oncology,Surgery

Reference26 articles.

1. Cholangiocarcinoma: epidemiology and risk factors;Khan;Liver Int.,2019

2. Local therapy reduces the risk of liver failure and improves survival in patients with intrahepatic cholangiocarcinoma: a comprehensive analysis of 362 consecutive patients;Yamashita;Cancer,2017

3. Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA);Banales;Nat. Rev. Gastroenterol. Hepatol.,2016

4. Intrahepatic cholangiocarcinoma: socioeconomic discrepancies, contemporary treatment approaches and survival trends from the National Center Database;Uhlig;Ann. Surg Oncol.,2019

5. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document;Khan;Gut,2002

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intrahepatic cholangiocarcinoma with arterial phase hyperenhancement and specialized tumor microenvironment associated with good prognosis after radical resection: A single-center retrospective study;Surgery;2024-08

2. Radiogenomics of Intrahepatic Cholangiocarcinoma: Correlation of Imaging Features With BAP1 and FGFR Molecular Subtypes;Journal of Computer Assisted Tomography;2024-07-05

3. Prognostic value of integrated morphofunctional imaging methods in inoperable intrahepatic cholangiocarcinoma;Frontiers in Medicine;2023-07-06